Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

Ophthalmology

Volumn 123, Issue 10, 2016, Pages 2248-2254

  da Cruz, Lyndon ^a   Dorn, Jessy D ^b   Humayun, Mark S ^c   Dagnelie, Gislin ^d   Handa, James ^d   Barale, Pierre Olivier ^e   Sahel, José Alain ^e,f,g   Stanga, Paulo E ⁱ   Hafezi, Farhad ^c,h,j   Safran, Avinoam B ^f,j   Salzmann, Joel ^j   Santos, Arturo ^k   Birch, David ^l   Spencer, Rand ^m   Cideciyan, Artur V ⁿ   de Juan, Eugene ^o   Duncan, Jacque L ^o   Eliott, Dean ^c,p   Fawzi, Amani ^c,q   Olmos de Koo, Lisa C ^c   Ho, Allen C ^r   Brown, Gary ^r   Haller, Julia ^d,r   Regillo, Carl ^r   Del Priore, Lucian V ^s   Arditi, Aries ^t   Greenberg, Robert J ^b   more..

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b Second Sight Medical Products Inc   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^f INSTITUT DE LA VISION   (France)

^g FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^h ELZA Institute   (Switzerland)

ⁱ UNIVERSITY OF MANCHESTER   (United Kingdom)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^k SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^l RETINA FOUNDATION OF THE SOUTHWEST   (United States)

^m TEXAS RETINA ASSOCIATES   (United States)

ⁿ UNIVERSITY OF PENNSYLVANIA   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p HARVARD MEDICAL SCHOOL   (United States)

^q NORTHWESTERN UNIVERSITY   (United States)

^r WILLS EYE HOSPITAL   (United States)

^s Howard Hughes Medical Institute   (United States)

^t and Visibility Metrics   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUDIOVISUAL EQUIPMENT; BLINDNESS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONJUNCTIVA DISEASE; CONJUNCTIVAL DEHISCENCE; CONJUNCTIVAL EROSION; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CORNEA DISEASE; CORNEA OPACITY; CORNEAL MELT; DEVICE SAFETY; ELECTRODE; ENDOPHTHALMITIS; EROSION; EUROPE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR HYPOTENSION; IRIS RUBEOSIS; KERATITIS; MALE; MEDICAL ELECTRONICS; MULTICENTER STUDY (TOPIC); NEOVASCULAR GLAUCOMA; OPHTHALMIC CAMERA; OPHTHALMOLOGICAL SURGICAL EQUIPMENT; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RETINA DEGENERATION; RETINA DETACHMENT; RETINA IMAGE; RETINA TEAR; RETINAL IMPLANT; RETINITIS PIGMENTOSA; SPECTACLES; SUTURE; UNITED STATES; UVEITIS; VISION; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PROSTHESIS DESIGN; REHABILITATION; RETINA; TIME FACTOR; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL PROSTHESIS; VISUALLY IMPAIRED PERSON;

ADULT; AGED; BLINDNESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RETINA; RETINITIS PIGMENTOSA; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL PROSTHESIS; VISUALLY IMPAIRED PERSONS;

EID: 84979230981     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2016.06.049     Document Type: Article

References (11)

1. 1 Petrs-Silva, H., Linden, R., Advances in gene therapy technologies to treat retinitis pigmentosa. Clin Ophthalmol 8 (2014), 127–136.
2. 2 Al-Shamekh, S., Goldberg, J.L., Retinal repair with induced pluripotent stem cells. Transl Res 163 (2014), 377–386.
3. 3 Stingl, K., Bartz-Schmidt, K.U., Besch, D., et al. Subretinal Visual Implant Alpha IMS–Clinical trial interim report. Vision Res 111:Pt B (2015), 149–160.
4. 4 Kitiratschky, V.B., Stingl, K., Wilhelm, B., et al. Safety evaluation of “retina implant alpha IMS”—a prospective clinical trial. Graefes Arch Clin Exp Ophthalmol 253 (2015), 381–387.
5. 5 Ayton, L.N., Blamey, P.J., Guymer, R.H., et al. First-in-human trial of a novel suprachoroidal retinal prosthesis. PLoS One 9 (2014), 1–26 e115239.
6. 6 Ho, A.C., Humayun, M.S., Dorn, J.D., et al. Long-term results from an epiretinal prosthesis to restore sight to the blind. Ophthalmology 122 (2015), 1547–1554.
7. 7 Humayun, M.S., Dorn, J.D., da Cruz, L., et al. Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology 119 (2012), 779–788.
8. 8 Ahuja, A.K., Dorn, J.D., Caspi, A., et al. Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task. Br J Ophthalmol 95 (2011), 539–543.
9. 9 Dorn, J.D., Ahuja, A.K., Caspi, A., et al. The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis. JAMA Ophthalmol 131 (2013), 183–189.
10. 10 Geruschat, D.R., Flax, M., Tanna, N., et al. FLORA: phase I development of a functional vision assessment for prosthetic vision users. Clin Exp Optom 98 (2015), 342–347.
11. 11 Geruschat, D.R., Richards, T.P., Arditi, A., et al. An analysis of observer-rated functional vision in patients implanted with the Argus II Retinal Prosthesis System at three years. Clin Exp Optom 99 (2016), 227–232.